Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Niconovum AB
AB
Active
Org 5565900791
Hyllie Boulevard 34, 215 32
Malmö
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2000 · 26 years old
10-19 employees
Monitor
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Niconovum AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
265M
199M
133M
66M
0M
2020: 190M
190M
2020
2021: 212M (+12% vs 2020)
212M
+12%
2021
2022: 213M (0% vs 2021)
213M
0%
2022
2023: 184M (-14% vs 2022)
184M
-14%
2023
2024: 127M (-31% vs 2023)
127M
-31%
2024
EBITDA
SEK millions
63M
29M
-6M
-40M
-74M
2020: 36M
36M
2020
2021: 29M (-19% vs 2020)
29M
-19%
2021
2022: 30M (+3% vs 2021)
30M
+3%
2022
2023: -11M (-137% vs 2022)
-11M
-137%
2023
2024: -47M (-327% vs 2023)
-47M
-327%
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
127 149
184 215
212 604
211 988
189 800
Staff expenses
—
—
—
—
—
EBITDA
−46 885
−11 256
29 975
28 741
36 240
Depreciation & amort.
−8 598
−8 857
−5 023
−22 224
−8 323
EBIT
−55 483
−20 113
24 952
6 517
27 917
Net financials
3 589
2 835
−516
−713
−733
Profit before tax
−11 846
351 087
24 436
5 804
27 184
Tax
−0
−72 119
−4 942
67 978
1 766
Net profit
−11 846
278 968
19 494
73 782
28 950
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
218 929
490 545
218 910
225 841
162 927
Equity
187 972
470 581
191 613
172 119
113 338
Long-term debt
0
0
0
11 000
11 000
Short-term debt
30 957
19 964
27 297
42 722
38 589
Total debt
30 957
19 964
27 297
53 722
49 589
Financial ratios
5-year trend
EBITDA margin
−36,9 %
This company
15,8 %
Market median
This company
Market median
334% below market
2020
2024
Equity ratio
85,9 %
This company
38,2 %
Market median
This company
Market median
125% above market
2020
2024
Return on equity
−6,3 %
This company
18,4 %
Market median
This company
Market median
134% below market
2020
2024
Net profit margin
−9,3 %
This company
8,1 %
Market median
This company
Market median
215% below market
2020
2024
Asset turnover
0,58×
This company
1,12×
Market median
This company
Market median
48% below market
2020
2024
Debt / equity
0,16×
This company
0,62×
Market median
This company
Market median
74% below market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Niconovum AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
